# A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

> **NCT00422162** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 339 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Duloxetine hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00422162
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 339 (ACTUAL)
- **Last updated:** 2011-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00422162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00422162, "A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00422162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*